• FirefoxInstall the new Firefox »
  •  Dow Down0.59% Nasdaq Down0.75%

    Synergy Pharmaceuticals, Inc. (SGYP)

    -NasdaqGS
    3.37 Up 0.05(1.51%) 1:56PM EST - Nasdaq Real Time Price
    Add to Portfolio
    ProfileGet Profile for:
    Synergy Pharmaceuticals, Inc.
    420 Lexington Avenue
    Suite 2012
    New York, NY 10170
    United States - Map
    Phone: 212-297-0020
    Fax: 212-297-0019
    Website: http://www.synergypharma.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Other
    Full Time Employees:25

    Business Summary 

    Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders, as well as is in Phase IIb clinical trials for the treatment of constipation-predominant irritable bowel syndrome GI disorders. The company also develops SP-333, which is in Phase II clinical trials to treat GI inflammatory diseases, such as ulcerative colitis. Synergy Pharmaceuticals Inc. is headquartered in New York, New York.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Synergy Pharmaceuticals, Inc.

    Corporate Governance 
    Synergy Pharmaceuticals, Inc.’s ISS Governance QuickScore as of Feb 1, 2015 is 7. The pillar scores are Audit: 2; Board: 7; Shareholder Rights: 2; Compensation: 10.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Dr. Gary S. Jacob Ph.D., 68
    Chairman, Chief Exec. Officer and Pres
    680.00K0.00
    Mr. Bernard F. Denoyer CPA, M.B.A., 67
    Principal Financial Officer, Principal Accounting Officer, Sr. VP of Fin. and Sec.
    279.00K0.00
    Dr. Kunwar Shailubhai Ph.D., 57
    Chief Scientific Officer
    368.00K0.00
    Mr. Marino Garcia ,
    Sr. VP of Corp. Devel.
    N/AN/A
    Dr. Laura Barrow Pharm. D.,
    Sr. VP of Clinical Operations
    N/AN/A
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders